27 February 2025, Evertis Commits £100m to Build New Production Facility in the US

Mar 5, 2025- by CMI| Category : Packaging1 min read
27 February 2025, Evertis Commits £100m to Build New Production Facility in the US

Portuguese packaging barriers maker Evertis plans to establish a new plant in Columbia, South Carolina.

The first part of the expansion will add capacity of 30,000 tonnes to the North American packaging sector and will be expected to create more than 100 new full-time positions for the region.

The move is targeting to meet increasing demand for reliable and effective packaging in North America. Evertis entered the US market in 2000 with production coming originally from plants located in Mexico and Brazil.

Based in France and founded in 1959, Evertis specializes in the manufacturing of food packaging and other uses in polymer applications of barrier films.

Evertis USA executive VP operations Thomaz Gruber stated: "This is another milestone in our road to getting our packaging to customers' doorsteps. The addition of the asset to our worldwide Group production base will allow us to provide shorter lead times, mitigate supply chain risks, and better conform to the growing market demand for packaging solutions."

According to coherent market insights, the flexible packaging industry is projected to expand at 5.5% CAGR in the forecast period 2025-2032. It is anticipated to be worth US$ 314.54 Bn in the year 2025 and will be worth US$ 457.85 Bn by the year 2032. Growth in the e-commerce industry and online shopping are anticipated to increase the size of the industry during the forecast period.

The global flexible packaging industry is poised to grow steadily over the coming years. The food and beverage industry remains the dominant end-use segment and demand from food manufacturers is expected to drive volumes says CMI’s senior consultant Kalpesh Gharte.

The new facility, with a total investment of £100 million, is set to begin operations in 2026, with its first commercial sales anticipated later that year.

Share this story

About the author

Ravina Pandya

is a seasoned content writer with over 3.5 years of hands-on experience across various writing formats, including news articles, blog posts, press releases, and informational content. Her expertise lies in producing high-quality, informative content tailored to meet the specific needs of diverse industries, such as Biotechnology, Clinical Diagnostic, Healthcare IT, advanced material, and Medical Devices. She has a deep understanding of how to craft engaging narratives that align with industry trends, helping businesses enhance their online presence and communicate effectively with their audiences.

What sets Ravina apart is her keen eye for detail and her passion for storytelling. She approaches every piece of content with the intent to make it not just informative but also impactful, ensuring that it resonates with the audience on a deeper level. With a reputation for producing timely and relevant articles, she has made significant contributions to the field by helping companies effectively communicate their brand message through engaging, clear, and creative writing. As an advocate for clarity in communication, she continues to explore new ways of refining her craft while remaining at the forefront of content trends.